Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers
- PMID: 16039637
- DOI: 10.1016/j.cccn.2005.06.010
Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers
Abstract
Background: Gaucher's disease (GD) is a disorder caused by the deficiency of lysosomal beta-glucosidase, an enzyme that participates in the degradation of glycosphingolipids. Deficiency of this enzyme results in the storage of glucocerebrosides in lysosomes of macrophage. No studies are available in the literature comparing biochemical and kinetic behavior of this enzyme in leukocytes and fibroblasts from normal individuals, obligate heterozygotes and patients with GD.
Methods: The behavior of beta-glu in terms of optimum pH, heat stability, Km and Vmax in leukocytes from patients with GD and obligated heterozygotes with different genotypes and normal individuals were characterized.
Results: Optimum pH was similar in all groups analyzed. In terms of Km and Vmax, several differences among heterozygotes and homozygotes groups and among these groups and normal enzyme were observed. Enzyme from all groups were inactivated when preincubated at 60 degrees C, but some enzymes were more stable than other. Results showed a different behavior of the enzyme in the 3 groups under analysis. Such behavior varied according to individual mutation.
Conclusions: The catalytic gradient presented by beta-glu allowed the correlation of N370S mutation-which presented more stable biochemical properties-with the non-neurological clinical condition of the disease and the catalytically less stable mutation (D409H), with the neurological clinical condition of GD. This study contributes to a better understanding of the repercussion of the different mutations on the protein function, thus allowing to predict the severity of such complex metabolic disorder and to anticipate the most appropriate intervention for each case specifically.
Similar articles
-
Biochemical study on beta-glucosidase in individuals with Gaucher's disease and normal subjects.Clin Chim Acta. 2004 May;343(1-2):145-53. doi: 10.1016/j.cccn.2004.01.010. Clin Chim Acta. 2004. PMID: 15115687
-
Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.Am J Med Genet. 1985 Jul;21(3):529-49. doi: 10.1002/ajmg.1320210316. Am J Med Genet. 1985. PMID: 3927728
-
Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease.Clin Biochem. 2007 Mar;40(5-6):365-9. doi: 10.1016/j.clinbiochem.2006.12.003. Epub 2007 Jan 8. Clin Biochem. 2007. PMID: 17291472
-
[Beta-glucosidases. Molecular bases of Gaucher's disease].Pathol Biol (Paris). 1985 Jun;33(6):693-713. Pathol Biol (Paris). 1985. PMID: 3931039 Review. French.
-
Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.Blood Cells Mol Dis. 2007 May-Jun;38(3):287-93. doi: 10.1016/j.bcmd.2006.11.003. Epub 2006 Dec 29. Blood Cells Mol Dis. 2007. PMID: 17196853 Review.
Cited by
-
Substrate compositional variation with tissue/region and Gba1 mutations in mouse models--implications for Gaucher disease.PLoS One. 2013;8(3):e57560. doi: 10.1371/journal.pone.0057560. Epub 2013 Mar 8. PLoS One. 2013. PMID: 23520473 Free PMC article.
-
LAMP2 as a marker of EBV-mediated B lymphocyte transformation in the study of lysosomal storage diseases.Mol Cell Biochem. 2014 Jan;385(1-2):1-6. doi: 10.1007/s11010-013-1806-4. Epub 2013 Sep 26. Mol Cell Biochem. 2014. PMID: 24068328
-
X-ray and biochemical analysis of N370S mutant human acid β-glucosidase.J Biol Chem. 2011 Jan 7;286(1):299-308. doi: 10.1074/jbc.M110.150433. Epub 2010 Oct 27. J Biol Chem. 2011. PMID: 20980263 Free PMC article.
-
Enzyme kinetics and inhibition parameters of human leukocyte glucosylceramidase.Heliyon. 2020 Nov 2;6(11):e05191. doi: 10.1016/j.heliyon.2020.e05191. eCollection 2020 Nov. Heliyon. 2020. PMID: 33163670 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical